1. Signaling Pathways
  2. Metabolic Enzyme/Protease
    Neuronal Signaling
  3. COMT


Catechol O-methyltransferase (COMT) is a ubiquitous bisubstrate magnesium-dependent enzyme found in plants, animals and microorganisms. COMT catalyses the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to one of the hydroxyl oxygen atoms (preferentially the 3-hydroxyl) in a catechol substrate. Physiological substrates of COMT are catecholamine neurotransmitters such as dopamine, noradrenaline, adrenaline and their metabolites. COMT also methylates catecholic steroids such as 2-hydroxyestradiol as well as a range of other catecholic compounds including neuroactive drugs such as L-dopa, α-methyldopa and isoproterenol. COMT inhibition is a means of treating Parkinson’s disease, schizophrenia and depression. There are two isoforms of human COMT: soluble cytoplasmic COMT (S-COMT), which is mainly intracellular, and a membrane-bound form (MB-COMT), which has a single-span helix contained within a 50 amino acid extension at the N-terminus.

COMT is an enzyme that plays a major role in catechol neurotransmitter deactivation. Inhibition of COMT can increase neurotransmitter levels, which provides a means of treatment for Parkinson’s disease, schizophrenia and depression.

COMT 相关产品 (7):

Cat. No. Product Name Effect Purity
  • HY-B1473
    Serotonin hydrochloride Inhibitor 99.97%
    Serotonin hydrochloride 是 CNS 中的单胺神经递质和内源性 5-HT 受体激动剂。Serotonin hydrochloride 也是儿茶酚 O-甲基转移酶 (COMT) 的抑制剂其 Ki 值为 44 μM。
  • HY-14280
    Entacapone Inhibitor 99.97%
    Entacapone是特异的外周活性的邻苯二酚-O-甲基转移酶(COMT)抑制剂,IC50为151 nM。
  • HY-17406
    Tolcapone Inhibitor 99.74%
    Tolcapone(Ro 40-7592)是口服活性的外周和中枢COMT抑制剂。
  • HY-14896
    Opicapone Inhibitor 99.60%
    Opicapone 是一种每日一次的、有效的第三代儿茶酚-O-甲基转移酶e (COMT)抑制剂,用于帕金森病和运动波动治疗。Opicapone 降低细胞 ATP 含量,IC50为 98 μM。
  • HY-100562
    Flopropione Inhibitor 98.37%
    Flopropione 是 5-HT 受体拮抗剂,也是儿茶酚-O-甲基转移酶 (COMT) 的抑制剂。Flopropione 也可作为解痉剂。
  • HY-106405
    Nebicapone Inhibitor
    Nebicapone (BIA 3-202) 是一种可逆的儿茶酚-O-甲基转移酶 (COMT) 抑制剂,主要通过葡萄糖醛酸化代谢。Nebicapone 主要是外周作用的抑制剂,通过抑制 COMT 降低 L-DOPA 向 3-O-甲基-DOPA 的生物转化,Nebicapone 具有治疗帕金森病的潜力。
  • HY-14280A
    Entacapone sodium salt Inhibitor
    Entacapone是特异的儿茶酚-o-甲基转移酶(COMT)抑制剂,IC50为151 nM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.